3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2/3
1
Status
Unknown
1
Recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Lymphoid
3
Sarcoma
2
Conditions
Sarcoma, Ewing
2
Sarcoma
2
Osteosarcoma
2
Lymphoma
2
Neoplasms
1
Interventions
Cyclophosphamide
58
Filgrastim
37
Radiotherapy
31
Busulfan
28
fludarabine phosphate
26
Antilymphocyte Serum
25
Cyclosporine
24
Peripheral Blood Stem Cell Transplantation
23
Etoposide
22
Methotrexate
20
Melphalan
18
Mycophenolic Acid
17
Cord Blood Stem Cell Transplantation
17
Methylprednisolone
16
Vincristine
13
Cytarabine
13
Tacrolimus
12
Rituximab
11
Whole-Body Irradiation
9
Thiotepa
9
Prednisone
9
Doxorubicin
8
Leucovorin
7
sargramostim
6
aldesleukin
6
Granulocyte Colony-Stimulating Factor
6
Psychiatric Rehabilitation
5
Daunorubicin
5
pembrolizumab
4
Sirolimus
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Lymphoma
×
Triptorelin Pamoate
×
Sarcoma
×
Clear all
NCT05328258
2023-10-27
ProFertil
Karolinska University Hospital
Phase 3
Recruiting
500 enrolled
NCT02856048
2019-12-17
PRESOV
Assistance Publique - Hôpitaux de Paris
Phase 2/3
Unknown
11 enrolled